Atlas Trials

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Clinical trial NCT03694834 · TERMINATED

Trial details

NCT number
NCT03694834
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Endometrial CancerUterine Cancer
Start date
2019-03-29
Primary completion
2023-10-23
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.